lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
8 rows where filing_uuid = "f6fcd45a-e52e-4fc0-811d-14e3b9cc99ee" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: specific_issues, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3440489 | ASSOCIATION FOR CLINICAL ONCOLOGY f6fcd45a-e52e-4fc0-811d-14e3b9cc99ee | Q3 | ASSOCIATION FOR CLINICAL ONCOLOGY | 401105592 | ASSOCIATION FOR CLINICAL ONCOLOGY | 2025 | third_quarter | MMM | H.R. 3514/S. 1816: Improving Seniors' Timely Access to Care Act of 2025 - requires Medicare Advantage plans to implement electronic prior authorization, increase transparency, protect enrollees, and adhere to new response timeframes to improve timely access to care. S. 1640: Medicare Patient Access and Practice Stabilization Act of 2025 - The bill extends Medicare payment adjustment timelines to 2025 and introduces an 8.51 percent adjustment for services between June 1, 2025, and January 1, 2026, to support healthcare providers in adapting to payment changes. S. 1460: Preserving Patient Access to Accountable Care Act - extends Medicare incentive payments for alternative payment models to 2027, with a new rate of 3.53 percent, to promote continued participation and improve healthcare efficiency. H.R. 4206/S. 1261: CONNECT for Health Act - expands access to telehealth services under Medicare H. 879: Medicare Patient Access and Practice Stabilization Act - Providing automatic inflationary updates to Medicare physician payments. Eliminate budget neutrality requirements. Meaningful changes to the Merit-Based Incentive Payment System (MIPS). H.R. 786: Preserving Patient Access to Accountable Care Act. Incentivizing the transition to value-based care. H.R. 2433: Reducing Medically Unnecessary Delays in Care Act - mandates that prior authorization decisions under Medicare be made by qualified physicians, based on medical necessity and evidence-based standards, with transparency and input from practicing physicians. H.R. 1509/S. 752: Accelerating Kids Access to Care Act - To amend titles XIX and XXI of the Social Security Act to streamline the enrollment process for eligible out-of-state providers under Medicaid and CHIP. H.R. 2484: Seniors' Access to Critical Medications Act of 2025 - establishes an exception to the physician self-referral prohibition for certain outpatient drugs under Medicare, mandates a study on drug dispensing practices, and reduces the Medicare improvement fund by $18 million. H.R. 2120/S. 1031: ROC… | HOUSE OF REPRESENTATIVES,SENATE | 110000 | 0 | 0 | 2025-10-17T11:43:35-04:00 | |
| 3440490 | ASSOCIATION FOR CLINICAL ONCOLOGY f6fcd45a-e52e-4fc0-811d-14e3b9cc99ee | Q3 | ASSOCIATION FOR CLINICAL ONCOLOGY | 401105592 | ASSOCIATION FOR CLINICAL ONCOLOGY | 2025 | third_quarter | HCR | S. 864: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes. S. 526: PBM Transparency Act - prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs H.R. 1262/S. 932: Give Kids a Chance Act of 2025 - To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. HR 929/S.266: Dr. Lorna Breen Health Care Provider Protection Reauthorization Act - To reauthorize the Dr. Lorna Breen Health Care Provider Protection Act, and for other purposes. H.R. 4191/S. 1784: MAPS Act - requires federal agencies to regularly update a list of essential medicines, assess and report on supply chain risks, map pharmaceutical supply chains, and enhance coordination and cybersecurity to protect public health and national security. H.R. 3955/S.2062: RAPID Reserve Act - establishes a $500 million program to create and maintain domestic reserves of critical drugs and their ingredients, prioritizing domestic manufacturing and supply chain resilience to prevent shortages during public health emergencies. S. 1954: Biosimilar Red Tape Elimination Act - streamlines the approval process for biosimilar biological products by automatically deeming them interchangeable with reference products, subject to certain exclusivity protections, and requires updated regulatory guidance to reflect these changes. H.R. 4191: To improve coordination of Federal efforts to identify and mitigate health and national security risks through maintaining a list of essential medicines, conducting a risk assessment of essential medicine supply chains, and creating a monitoring system to map essential medicine supply chains using data analytics. H.R. 4101: Cancer Drug Parity Act of 2025 - requires group health plans to provide cost-sharing for oral antica… | HOUSE OF REPRESENTATIVES,SENATE | 110000 | 0 | 0 | 2025-10-17T11:43:35-04:00 | |
| 3440491 | ASSOCIATION FOR CLINICAL ONCOLOGY f6fcd45a-e52e-4fc0-811d-14e3b9cc99ee | Q3 | ASSOCIATION FOR CLINICAL ONCOLOGY | 401105592 | ASSOCIATION FOR CLINICAL ONCOLOGY | 2025 | third_quarter | TOB | Support banning the sale of menthol cigarettes and flavored cigars Support regulating the sale of flavored tobacco and electronic nicotine devices | HOUSE OF REPRESENTATIVES,SENATE | 110000 | 0 | 0 | 2025-10-17T11:43:35-04:00 | |
| 3440492 | ASSOCIATION FOR CLINICAL ONCOLOGY f6fcd45a-e52e-4fc0-811d-14e3b9cc99ee | Q3 | ASSOCIATION FOR CLINICAL ONCOLOGY | 401105592 | ASSOCIATION FOR CLINICAL ONCOLOGY | 2025 | third_quarter | BUD | FY 2025 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP) and palliative care research. FY 2026 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP). H.R. 1: One Big Beautiful Bill Act - Provisions related to Medicare physician payment, PBM reform, Medicaid | HOUSE OF REPRESENTATIVES,SENATE | 110000 | 0 | 0 | 2025-10-17T11:43:35-04:00 | |
| 3712556 | ASSOCIATION FOR CLINICAL ONCOLOGY f6fcd45a-e52e-4fc0-811d-14e3b9cc99ee | Q3 | ASSOCIATION FOR CLINICAL ONCOLOGY | 401105592 | ASSOCIATION FOR CLINICAL ONCOLOGY | 2025 | third_quarter | MMM | H.R. 3514/S. 1816: Improving Seniors' Timely Access to Care Act of 2025 - requires Medicare Advantage plans to implement electronic prior authorization, increase transparency, protect enrollees, and adhere to new response timeframes to improve timely access to care. S. 1640: Medicare Patient Access and Practice Stabilization Act of 2025 - The bill extends Medicare payment adjustment timelines to 2025 and introduces an 8.51 percent adjustment for services between June 1, 2025, and January 1, 2026, to support healthcare providers in adapting to payment changes. S. 1460: Preserving Patient Access to Accountable Care Act - extends Medicare incentive payments for alternative payment models to 2027, with a new rate of 3.53 percent, to promote continued participation and improve healthcare efficiency. H.R. 4206/S. 1261: CONNECT for Health Act - expands access to telehealth services under Medicare H. 879: Medicare Patient Access and Practice Stabilization Act - Providing automatic inflationary updates to Medicare physician payments. Eliminate budget neutrality requirements. Meaningful changes to the Merit-Based Incentive Payment System (MIPS). H.R. 786: Preserving Patient Access to Accountable Care Act. Incentivizing the transition to value-based care. H.R. 2433: Reducing Medically Unnecessary Delays in Care Act - mandates that prior authorization decisions under Medicare be made by qualified physicians, based on medical necessity and evidence-based standards, with transparency and input from practicing physicians. H.R. 1509/S. 752: Accelerating Kids Access to Care Act - To amend titles XIX and XXI of the Social Security Act to streamline the enrollment process for eligible out-of-state providers under Medicaid and CHIP. H.R. 2484: Seniors' Access to Critical Medications Act of 2025 - establishes an exception to the physician self-referral prohibition for certain outpatient drugs under Medicare, mandates a study on drug dispensing practices, and reduces the Medicare improvement fund by $18 million. H.R. 2120/S. 1031: ROC… | HOUSE OF REPRESENTATIVES,SENATE | 110000 | 0 | 0 | 2025-10-17T11:43:35-04:00 | |
| 3712557 | ASSOCIATION FOR CLINICAL ONCOLOGY f6fcd45a-e52e-4fc0-811d-14e3b9cc99ee | Q3 | ASSOCIATION FOR CLINICAL ONCOLOGY | 401105592 | ASSOCIATION FOR CLINICAL ONCOLOGY | 2025 | third_quarter | HCR | S. 864: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes. S. 526: PBM Transparency Act - prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs H.R. 1262/S. 932: Give Kids a Chance Act of 2025 - To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. HR 929/S.266: Dr. Lorna Breen Health Care Provider Protection Reauthorization Act - To reauthorize the Dr. Lorna Breen Health Care Provider Protection Act, and for other purposes. H.R. 4191/S. 1784: MAPS Act - requires federal agencies to regularly update a list of essential medicines, assess and report on supply chain risks, map pharmaceutical supply chains, and enhance coordination and cybersecurity to protect public health and national security. H.R. 3955/S.2062: RAPID Reserve Act - establishes a $500 million program to create and maintain domestic reserves of critical drugs and their ingredients, prioritizing domestic manufacturing and supply chain resilience to prevent shortages during public health emergencies. S. 1954: Biosimilar Red Tape Elimination Act - streamlines the approval process for biosimilar biological products by automatically deeming them interchangeable with reference products, subject to certain exclusivity protections, and requires updated regulatory guidance to reflect these changes. H.R. 4191: To improve coordination of Federal efforts to identify and mitigate health and national security risks through maintaining a list of essential medicines, conducting a risk assessment of essential medicine supply chains, and creating a monitoring system to map essential medicine supply chains using data analytics. H.R. 4101: Cancer Drug Parity Act of 2025 - requires group health plans to provide cost-sharing for oral antica… | HOUSE OF REPRESENTATIVES,SENATE | 110000 | 0 | 0 | 2025-10-17T11:43:35-04:00 | |
| 3712558 | ASSOCIATION FOR CLINICAL ONCOLOGY f6fcd45a-e52e-4fc0-811d-14e3b9cc99ee | Q3 | ASSOCIATION FOR CLINICAL ONCOLOGY | 401105592 | ASSOCIATION FOR CLINICAL ONCOLOGY | 2025 | third_quarter | TOB | Support banning the sale of menthol cigarettes and flavored cigars Support regulating the sale of flavored tobacco and electronic nicotine devices | HOUSE OF REPRESENTATIVES,SENATE | 110000 | 0 | 0 | 2025-10-17T11:43:35-04:00 | |
| 3712559 | ASSOCIATION FOR CLINICAL ONCOLOGY f6fcd45a-e52e-4fc0-811d-14e3b9cc99ee | Q3 | ASSOCIATION FOR CLINICAL ONCOLOGY | 401105592 | ASSOCIATION FOR CLINICAL ONCOLOGY | 2025 | third_quarter | BUD | FY 2025 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP) and palliative care research. FY 2026 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP). H.R. 1: One Big Beautiful Bill Act - Provisions related to Medicare physician payment, PBM reform, Medicaid | HOUSE OF REPRESENTATIVES,SENATE | 110000 | 0 | 0 | 2025-10-17T11:43:35-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);